Look Up > Drugs > Dexchlorpheniramine
Dexchlorpheniramine
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Dietary Considerations
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(deks klor fen EER a meen)

U.S. Brand Names
Dexchlor®; Poladex®; Polaramine®

Generic Available

Yes


Synonyms
Dexchlorpheniramine Maleate

Pharmacological Index

Antihistamine


Use

Perennial and seasonal allergic rhinitis and other allergic symptoms including urticaria


Pregnancy Risk Factor

B


Contraindications

Narrow-angle glaucoma, hypersensitivity to dexchlorpheniramine or any component


Warnings/Precautions

Bladder neck obstruction, symptomatic prostatic hypertrophy, asthmatic attack, and stenosing peptic ulcer


Adverse Reactions

>10%:

Central nervous system: Slight to moderate drowsiness

Respiratory: Thickening of bronchial secretions

1% to 10%:

Central nervous system: Headache, fatigue, nervousness, dizziness

Gastrointestinal: Appetite increase, weight increase, nausea, diarrhea, abdominal pain, xerostomia

Neuromuscular & skeletal: Arthralgia

Respiratory: Pharyngitis


Overdosage/Toxicology

Symptoms of overdose include dry mouth, flushed skin, dilated pupils, CNS depression. There is no specific treatment for antihistamine overdose. Clinical toxicity is due to blockade of cholinergic receptors. For anticholinergic overdose with severe life-threatening symptoms, physostigmine 1-2 mg I.V. slowly, may be given to reverse these effects.


Drug Interactions

Increased effect/toxicity: CNS depressants, MAO inhibitors, TCAs, phenothiazines, guanabenz


Mechanism of Action

Competes with histamine for H1-receptor sites on effector cells in the gastrointestinal tract, blood vessels, and respiratory tract


Pharmacodynamics/Kinetics

Onset of action: ~1 hour

Duration: 3-6 hours

Absorption: Well absorbed from GI tract


Usual Dosage

Oral:

2-5 years: 0.5 mg every 4-6 hours (do not use timed release)

6-11 years: 1 mg every 4-6 hours or 4 mg timed release at bedtime

Adults: 2 mg every 4-6 hours or 4-6 mg timed release at bedtime or every 8-10 hours


Dietary Considerations

May be administered with food or water


Mental Health: Effects on Mental Status

Drowsiness is common; may cause nervousness and depression


Mental Health: Effects on Psychiatric Treatment

Concurrent use with psychotropics may cause additive sedation


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

Up to 10% of patients will complain of significant dry mouth and drowsiness. This will disappear with cessation of drug therapy.


Patient Information

Take as directed; do not exceed recommended dose. Do not chew or crush sustained release tablet. Avoid use of other depressants, alcohol, or sleep-inducing medications unless approved by prescriber. You may experience drowsiness or dizziness (use caution when driving or engaging in tasks requiring alertness until response to drug is known); or dry mouth, nausea, or abdominal pain (frequent small meals, frequent mouth care, chewing gum, or sucking hard candy may help). Report persistent sedation, confusion, or agitation; changes in urinary pattern; blurred vision; sore throat, difficulty breathing or expectorating (thick secretions); or lack of improvement or worsening or condition. Breast-feeding precautions: Breast-feeding is not recommended.


Nursing Implications

May cause drowsiness; swallow whole, do not crush or chew sustained release product; avoid alcohol, may impair coordination and judgment


Dosage Forms

Syrup, as maleate (orange flavor): 2 mg/5 mL with alcohol 6% (480 mL)

Tablet, as maleate: 2 mg

Tablet, as maleate, sustained action: 4 mg, 6 mg


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved